Mycobacterium tuberculosis Meets the Cytosol: The Role of cGAS in Anti-mycobacterial Immunity  by Majlessi, Laleh & Brosch, Roland
Mycobacterium tuberculosisMeets the Cytosol:
The Role of cGAS in Anti-mycobacterial Immunity
Laleh Majlessi1 and Roland Brosch1,*
1Institut Pasteur, Unit for Integrated Mycobacterial Pathogenomics, Institut Pasteur, 25 rue du Dr. Roux, Paris 75015, France
*Correspondence: roland.brosch@pasteur.fr
http://dx.doi.org/10.1016/j.chom.2015.05.017
The intracellular fate of Mycobacterium tuberculosis is a subject of long debate. In this issue of Cell Host &
Microbe, three independent studies reveal the detection of cytosolic mycobacterial DNA by the nucleotidyl-
transferase cGAS, emphasizing the concept of cytosolic access byM. tuberculosis and its role in balancing
immune-protection and immune-pathogenesis.
Mycobacterium tuberculosis, the etiolog-
ical agent of human tuberculosis, is one
of the most devastating pathogens in
the history of mankind and continues
to cause millions of active tuberculosis
cases and more than a million deaths
each year. This bacterium, which appar-
ently evolved from a Mycobacterium
canettii-like ancestor into an extremely
widespread, aerosol-transmitted human
pathogen (Boritsch et al., 2014), has
developed the ability to circumvent
many of the bactericidal mechanisms
employed by the host. The interaction of
M. tuberculosis with the host is highly
complex, involving dedicated mycobac-
terial virulence factors as well as the ac-
tion of the innate and adapted immune
system, which is decisive for the control
of infection or development of disease.
A central role in this process is played by
macrophages (Mf), which are the first to
encounter the pathogen upon entry into
the lungs, resulting in uptake and enclo-
sure of M. tuberculosis in a phagosomal
vacuole inside the Mf. While this initial
cellular process is meant to eliminate
phagocytized bacteria, M. tuberculosis
has developed efficient strategies to
prevent degradation and killing (reviewed
in Majlessi et al., 2015 and Cambier et al.,
2014).
In this context, three new independent
studies in this issue ofCell Host &Microbe
(Collins et al., 2015; Wassermann et al.,
2015; Watson et al., 2015) explore the
involvement of cyclic guanosine mono-
phosphate-AMP (cyclic GMP-AMP, or
cGAMP) synthase (cGAS) in sensing
mycobacterial DNA and its cellular and
immunological consequences, offering
new insights into a fascinating chapter of
mycobacterial host-pathogen research
that has a long history of scientific excite-
ment and critical discussion (reviewed in
Majlessi et al., 2015).
In 1971, Armstrong andD’Arcy Hart first
proposed that M. tuberculosis resists
degradation in the phagosome by inhibit-
ing fusion with lysosomes, favoring intra-
phagosomal survival and multiplication.
Based on this landmark study and follow-
up investigations, the paradigm emerged
that intracellular M. tuberculosis resides
and multiplies within a membrane-
enclosed compartment, which is mani-
pulated by the bacterium in a way that
prevents maturation and acidification.
Although thismodel of exclusive phagoso-
mal containment is consistent with the
production of dominant CD4+ T cell
responses specific to MHC-II-restricted
epitopes derived from vacuole-resident
microorganisms, the observed type I
interferon (IFN) responses and activation
of the cytosolic NLRP3 inflammasome
suggest that M. tuberculosis also
undergoes cytosolic stages during
infection. While phagosomal egress of
M. tuberculosis was evoked by several
studies in the eighties and early nineties,
including one by McDonough and col-
leagues in 1993, the subject remained
debated (reviewed in Majlessi et al.,
2015). A significant change in the per-
ception of the field came about only more
recently. First, a study by van der
Wel and colleagues in 2007 used sophisti-
cated cryo-electron microscopy to pro-
vide compelling evidence of apparent
cytosolic presence of M. tuberculosis at
later stages of infection. Then, in 2012, a
collaborative study involving our group
and that of J. Enninga demonstrated
cytosolic access of M. tuberculosis in
THP-1 humanMf by using a fluorescence
resonance energy transfer (FRET)-based
method. The latter approach relies on a
change in the emission spectrum of a
CCF-4 substrate due to b-lactamase-
mediated cleavage of the substrate upon
contact with M. tuberculosis. In both
of these studies, cytosolic access of
M. tuberculosis was dependent on the
mycobacterial type VII secretion system
ESX-1and its secretedeffectors, including
the 6 kDa early secretory antigenic target
ESAT-6 (also named EsxA), which has
been shown to possess membranolytic
activity. The ESX-1 system, which is
absent from the live attenuated vaccine
Mycobacterium bovis BCG due to the
deletion of the region of difference 1
(RD1), is thus critical for cytosolic access
of M. tuberculosis and the associated
cell-biological parameters, which differ
substantially between M. tuberculosis
and BCG despite close genetic similarity
(reviewed in Majlessi et al., 2015 and
Boritsch et al., 2014). Finally, cytosolic
access of M. tuberculosis is relevant not
only in cultured phagocytes, but also
in vivo, as recently demonstrated in an
experimental mouse infection model that
used a highly sensitive FRET-based
detection method adapted for flow cyto-
metry (Simeone et al., 2015). This study
also showed that phagosomal membrane
disruption occurred as early as 3 hours
post-infection, consistent with the early
kinetics of type I IFNproduction. However,
the main contact of M. tuberculosis with
the host cytosol built up over time to be
at its maximum 2–3 days post-infection
(Simeone et al., 2015), in agreement
with aforementioned cryo-electron micro-
scopy data.
From the comparison of ESX-1 profi-
cient and deficient strains, it is clear
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that cytosolic access has
numerous consequences on
the activation of different
axes of innate immunity,
among which the induction
of type I IFN production may
be considered as a pro-
bacterial event, whereas the
activation of the inflam-
masome and triggering of
autophagy are thought to
benefit the host. These
opposing responses govern
the balance between im-
mune-pathogenesis and im-
mune-protection.
The three new studies on
the role of cGAS in anti-
mycobacterial immunity now
report on the cellular sig-
naling events underlying this
delicate balance. The nu-
cleotidyltransferase cGAS is
known to induce synthesis
of type I IFN via cGAMP
in response to cytosolic
DNA derived from DNA vi-
ruses or HIV (reviewed in Cai
et al., 2014). Similarly, cyto-
solic M. tuberculosis DNA is
now found to induce the
cGAMP signaling cascade
in infected human and
murine Mf. The detection of
M. tuberculosis DNA by
cGAS depends on ESX-1
and its secreted effectors,
suggesting that signaling de-
pends on pathogen-induced
phagosomal rupture. The
combined results support a
model whereby subsequent
to M. tuberculosis infection,
cGAS and mycobacterial
DNA co-localize in the Mf cytoplasm
and form aggregates. This interaction ini-
tiates the synthesis of cGAMP by cGAS
and consequent activation of the STING-
TBK-1-IRF-3 signaling axis that drives
transcription of IFN-b (Figure 1). cGAMP
can also be transferred via gap junctions
to adjacent bystander Mf, which will
thus be efficiently activated without
being infected (Wassermann et al., 2015).
However,within the host cytosol,myco-
bacterial DNA is also sensed by AIM-2, a
sensor of the NLRP3 inflammasome
complex that promotes the maturation
of protective cytokines such as IL-1b.
Interestingly, the cGAS-STING-TBK-1-
IRF-3-IFN-I pro-bacterial axis and the
AIM-2-NLRP3-IL-1b pro-host pathway
were found to be exploited distinctly
by different M. tuberculosis ESX-1 mu-
tants (Wassermann et al., 2015). In
THP-1 human Mf, ESX-1 deficient
M. tuberculosis strains were unable to
activate either of these two pathways,
while certain M. tuberculosis secretion
mutants (e.g., attenuated strain H37Ra or
EspA/C transposon mutants), which ex-
press but do not secrete ESAT-6 (EsxA),
continued to activate IL-1b, but not IFN-b
production.
The ESX-1 system is also
instrumental in mediating
recruitment of the lipidated
isoform of LC3 (LC3-II), which
is associated with auto-
phagosomes. This process is
mediated via the cGAS recog-
nition of mycobacterial DNA
and is involved in ubiquitin-
mediated activation of auto-
phagy (Watson et al., 2015).
However, ESX-1-dependent
LC3-II recruitment has also
been shown as being involved
in the impairment of autopha-
gic flux in human dendritic
cells (Romagnoli et al., 2012),
suggesting that the process
is complex and possibly cell-
type dependent.
Given the newly defined role
of cGAS in anti-mycobacterial
immunity derived from in vitro
and ex vivo data, it will be
interesting to learnmore about
the role of cGAS in vivo to
know which of the pro-bacte-
rial or pro-host-mediated roles
emerges as being dominant
there. Some insights come
from one of the studies, where
cGAS/ mice challenged
with virulent M. tuberculosis
displayed reduced serum
IFN-b levels, but increased
lethality at late stages of infec-
tion, relative towild-typemice,
while the bacterial load was
equal in both groups (Collins
et al., 2015). More studies are
warranted in the future, also
to evaluate how mycobac-
terial antigen presentation
and adaptive immunity are
impacted in the absence of cGAS
signaling.
Finally, one of the puzzling points to
be considered is where the DNA that is
sensed by cGAS comes from. Given that
M. tuberculosis needs active secretion of
ESX-1 effectors to gain access to the
cytosol, mycobacterial DNA sensed by
cGAS should thus originate from living
bacteria and not from degraded ones.
Possible explanations could be that
M. tuberculosis buds off vesicles that
contain mycobacterial DNA (reviewed in
Majlessi et al., 2015) or that the bacterium
releases DNAby othermeans, such as the
Figure 1. Schematic of a Phagocyte Infected with M. tuberculosis
and the Different Events Related to Cytosolic Translocation of
Bacterial DNA
The major mycobacterial virulence factor ESAT-6 (EsxA), secreted together
with its protein partner EsxB and associated proteins EspA and EspC, by
the type VII secretion system of M. tuberculosis, induce phagosome mem-
brane rupture within the infected Mf. This event triggers cytosolic transloca-
tion of mycobacterial effector molecules such as DNA. (i) The latter is sensed
by cGAS, which synthesizes the second messenger cGAMP from ATP and
GTP. cGAMP activates the ER-associated STING and the downstream TBK-
1-IRF-3-IFN-b signaling axis. cGAMP can also disseminate to bystander
non-infected Mf to spread the cell activation. (ii) The ESX-1-mediated cyto-
solic translocation of bacterial DNA and the resultant activation of TBK-1
also initiate autophagy via recruitment of LC3-II involved in bacteria ubiquitina-
tion. (iii) The cytosolic bacterial DNA can also be sensed by AIM-2, which
contributes partially to the activation of the inflammasome axis and release
of mature IL-1b.
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type VII secretion system. More research
is also warranted here.
Together, the results shown in the
three articles present exciting new in-
sights into the tuberculosis-related host-
pathogen interaction and raise many new
questions and challenges for future work
onM. tuberculosis pathogenicity and vac-
cine design (Bottai et al., 2015). The mo-
lecular details on themechanisms through
whichM. tuberculosis gains access to the
host cytosol and the biological conse-
quences remain of central importance.
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